India to Poland: Loperamide Export Trade Route

The India to Poland Loperamide corridor is one of India's established pharmaceutical export routes, with 56 shipments documented worth a combined $3.3M USD. The route is dominated by STRIDES PHARMA SCIENCE LIMITED, which alone accounts for roughly 52% of all export value, reflecting the consolidated nature of India's loperamide manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $58.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 15.0%, placing it at rank #12 among India's top loperamide export destinations globally.

On the import side, key buyers of Indian loperamide in Poland include NA, US PHARMACIA Sp.zo.o,, US PHARMACIA SP.ZO.O and 6 others. NA is the single largest importer with 7 shipments valued at $1.0M USD.

India's loperamide exports to Poland are driven primarily by a handful of large-scale manufacturers. STRIDES PHARMA SCIENCE LIMITED with 30 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — STRIDES PHARMA SCIENCE LIMITED, IPCA LABORATORIES LIMITED, STRIDES PHARMA SCIENCE LIMITED — together account for 97% of total trade value on this route. The average shipment value of $58.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as stoperan loperamide hydrochloride capsul and stoperan loperamide hydrochloride capsul , suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 7 shipments worth $1.0M USD — representing 32% of all loperamide imports from India on this route. A total of 9 buyers are active on this corridor.